Evidence map›Paper›PMID 36613596›Full record

ArticleInternational journal of molecular sciences2022

Analysis of Serum Advanced Glycation Endproducts Reveals Methylglyoxal-Derived Advanced Glycation MG-H1 Free Adduct Is a Risk Marker in Non-Diabetic and Diabetic Chronic Kidney Disease.

Naila Rabbani, Antonysunil Adaikalakoteswari, James R Larkin, Sianna Panagiotopoulos, Richard J MacIsaac, Dennis K Yue, Gregory R Fulcher, Matthew A Roberts, Merlin Thomas, Elif Ekinci and 1 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 18 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 3 countries.

Naila RabbaniDepartment of Basic Medical Science, College of Medicine, QU Health, Qatar University, Doha P.O. Box 2713, Qatar.ORCID 0000-0002-5819-2506
Antonysunil AdaikalakoteswariClinical Sciences Research Laboratories, Warwick Medical School, University of Warwick, University Hospital, Coventry CV2 2DX, UK.ORCID 0000-0003-2974-3388
James R LarkinClinical Sciences Research Laboratories, Warwick Medical School, University of Warwick, University Hospital, Coventry CV2 2DX, UK.ORCID 0000-0002-4169-8447
Sianna PanagiotopoulosEndocrine Centre, Austin Health, The University of Melbourne, West Heidelberg, VIC 3084, Australia.
Richard J MacIsaacDepartment of Endocrinology & Diabetes, St Vincent's Hospital Melbourne, Fitzroy, VIC 3065, Australia.ORCID 0000-0001-8058-6977
Dennis K YueDiabetes Centre, Royal Prince Alfred Hospital, Camperdown, NSW 2050, Australia.
Gregory R FulcherDepartment of Diabetes, Endocrinology & Metabolism, Royal North Shore Hospital, St Leonards, NSW 2065, Australia.
Matthew A RobertsEastern Health Clinical School, Monash University, Box Hill, VIC 3128, Australia.ORCID 0000-0003-1665-3455
Merlin ThomasDepartment of Diabetes, Monash University, Melbourne, VIC 3004, Australia.ORCID 0000-0003-0694-8743
Elif EkinciEndocrine Centre, Austin Health, The University of Melbourne, West Heidelberg, VIC 3084, Australia.
Paul J ThornalleyClinical Sciences Research Laboratories, Warwick Medical School, University of Warwick, University Hospital, Coventry CV2 2DX, UK.ORCID 0000-0001-7659-443X
The University of Melbourne · AUUniversity Hospital Coventry · GBEastern Health · AUMonash University · AUQatar University · QARoyal North Shore Hospital · AURoyal Prince Alfred Hospital · AU

Funding

Austin Hospital Medical Research Foundation Grant 2003National Health and Medical Research Council 310632Qatar Foundation QB-14Qatar University QU ERG-CMED-2020-1
6 · The paper itself

Abstract

Accumulation of advanced glycation endproducts (AGEs) is linked to decline in renal function, particularly in patients with diabetes. Major forms of AGEs in serum are protein-bound AGEs and AGE free adducts. In this study, we assessed levels of AGEs in subjects with and without diabetes, with normal renal function and stages 2 to 4 chronic kidney disease (CKD), to identify which AGE has the greatest progressive change with decline in renal function and change in diabetes. We performed a cross-sectional study of patients with stages 2-4 CKD, with and without diabetes, and healthy controls (

Indexed as

Diabetes MellitusDiabetic NephropathiesRenal Insufficiency, ChronicCross-Sectional StudiesGlycation End Products, AdvancedHumansMaillard ReactionPyruvaldehydeGlycation End Products, AdvancedPyruvaldehydechronic kidney diseasediabetesestimated glomerular filtration rateglycationmethylglyoxal

Identifiers

PMID36613596
PMCPMC9820473
OpenAlexW4312175636

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.